Dawn Halkuff
Vermögen: 986 856 $ am 30.06.2026
Vermögen: 986 856 $ am 30.06.2026
Dawn Halkuff is Director at Society For Women's Health Research since 2017.
Ms. Halkuff is Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Ideal Protein of America, Inc. from 2021 to 2024, Chief Executive Officer at Laboratoires C.O.P., Inc. from 2021 to 2024, Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. from 2018 to 2021, Senior Vice President-Consumer Healthcare at Pfizer Inc. from 2010 to 2016, Head-Global Innovation at WW International, Inc. from 2005 to 2010, and Chief Commercial Officer at TherapeuticsMD, Inc. from 2016 to 2021.
Education includes an MBA from The Pennsylvania State University in 1997 and an undergraduate degree from the University of Connecticut in 1992.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 124’603 ( 0.07% ) | 986 856 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 05.10.2021 |
Society For Women's Health Research
Society For Women's Health Research Miscellaneous Commercial ServicesCommercial Services Engages in promoting research on biological differences in disease | Direktor/Vorstandsmitglied | 13.07.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Ideal Protein of America, Inc.
Ideal Protein of America, Inc. Other Consumer ServicesConsumer Services Provides dieters with continuing education services and sells weight loss nutrition products | Vorstandsvorsitzender | 01.03.2024 |
Laboratoires C.O.P., Inc.
Laboratoires C.O.P., Inc. Other Consumer ServicesConsumer Services Provides medical weight loss program | Vorstandsvorsitzender | 01.01.2024 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Direktor/Vorstandsmitglied | 05.10.2021 |
| THERAPEUTICSMD, INC. | Corporate Officer/Principal | 01.09.2021 |
| PFIZER INC. | Corporate Officer/Principal | 01.10.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
WW International, Inc.
WW International, Inc. Other Consumer ServicesConsumer Services Operates weight management programs and digital subscription platform | Consumer Services |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Society For Women's Health Research
Society For Women's Health Research Miscellaneous Commercial ServicesCommercial Services Engages in promoting research on biological differences in disease | Commercial Services |
TherapeuticsMD, Inc.
TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Ideal Protein of America, Inc.
Ideal Protein of America, Inc. Other Consumer ServicesConsumer Services Provides dieters with continuing education services and sells weight loss nutrition products | Consumer Services |
Laboratoires C.O.P., Inc.
Laboratoires C.O.P., Inc. Other Consumer ServicesConsumer Services Provides medical weight loss program | Consumer Services |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen